Theseus Pharmaceuticals Statistics
Total Valuation
NCI has a market cap or net worth of $9.00 million. The enterprise value is $16.78 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NCI has 4.66 million shares outstanding. The number of shares has increased by 8.91% in one year.
| Current Share Class | 4.06M |
| Shares Outstanding | 4.66M |
| Shares Change (YoY) | +8.91% |
| Shares Change (QoQ) | +7.53% |
| Owned by Insiders (%) | 7.72% |
| Owned by Institutions (%) | 0.21% |
| Float | 945,240 |
Valuation Ratios
The trailing PE ratio is 7.40.
| PE Ratio | 7.40 |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| Forward PS | n/a |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 163.27 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 16.17 |
| EV / Sales | 0.55 |
| EV / EBITDA | 9.49 |
| EV / EBIT | 11.26 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 1.22.
| Current Ratio | 1.84 |
| Quick Ratio | 1.13 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | 3.95 |
| Debt / FCF | n/a |
| Interest Coverage | 3.08 |
Financial Efficiency
Return on equity (ROE) is 29.62% and return on invested capital (ROIC) is 8.10%.
| Return on Equity (ROE) | 29.62% |
| Return on Assets (ROA) | 6.39% |
| Return on Invested Capital (ROIC) | 8.10% |
| Return on Capital Employed (ROCE) | 12.01% |
| Revenue Per Employee | $1.26M |
| Profits Per Employee | $43,254 |
| Employee Count | 24 |
| Asset Turnover | 2.08 |
| Inventory Turnover | 41.67 |
Taxes
In the past 12 months, NCI has paid $139,802 in taxes.
| Income Tax | 139,802 |
| Effective Tax Rate | 11.87% |
Stock Price Statistics
The stock price has decreased by -21.38% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -21.38% |
| 50-Day Moving Average | 2.07 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 44.85 |
| Average Volume (20 Days) | 84,236 |
Short Selling Information
The latest short interest is 63,964, so 1.37% of the outstanding shares have been sold short.
| Short Interest | 63,964 |
| Short Previous Month | 103,908 |
| Short % of Shares Out | 1.37% |
| Short % of Float | 6.77% |
| Short Ratio (days to cover) | 0.35 |
Income Statement
In the last 12 months, NCI had revenue of $30.34 million and earned $1.04 million in profits. Earnings per share was $0.26.
| Revenue | 30.34M |
| Gross Profit | 6.37M |
| Operating Income | 1.49M |
| Pretax Income | 736,928 |
| Net Income | 1.04M |
| EBITDA | 1.77M |
| EBIT | 1.49M |
| Earnings Per Share (EPS) | $0.26 |
Full Income StatementBalance Sheet
The company has $1.18 million in cash and $8.96 million in debt, giving a net cash position of -$7.78 million or -$1.67 per share.
| Cash & Cash Equivalents | 1.18M |
| Total Debt | 8.96M |
| Net Cash | -7.78M |
| Net Cash Per Share | -$1.67 |
| Equity (Book Value) | 7.32M |
| Book Value Per Share | 1.80 |
| Working Capital | 4.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $55,133 and capital expenditures -$533,501, giving a free cash flow of -$473,343.
| Operating Cash Flow | 55,133 |
| Capital Expenditures | -533,501 |
| Free Cash Flow | -473,343 |
| FCF Per Share | -$0.10 |
Full Cash Flow StatementMargins
Gross margin is 20.98%, with operating and profit margins of 4.91% and 3.42%.
| Gross Margin | 20.98% |
| Operating Margin | 4.91% |
| Pretax Margin | 3.88% |
| Profit Margin | 3.42% |
| EBITDA Margin | 5.83% |
| EBIT Margin | 4.91% |
| FCF Margin | n/a |
Dividends & Yields
NCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.91% |
| Shareholder Yield | -8.91% |
| Earnings Yield | 11.53% |
| FCF Yield | -5.26% |
Dividend DetailsAnalyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on June 16, 2025. It was a reverse split with a ratio of 1:5.
| Last Split Date | Jun 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
NCI has an Altman Z-Score of 2.68 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.68 |
| Piotroski F-Score | 5 |
